@article{06f50beef9574cd68d868af0326f2170,
title = "Alectinib impressively enters the adjuvant setting for early-stage ALK-rearranged non-small cell lung cancer and outperforms chemotherapy-let's define who benefits the most",
keywords = "Adjuvant alectinib, anaplastic lymphoma kinaserearranged NSCLC (ALK-rearranged NSCLC), resected early-stage non-small cell lung cancer (resected early-stage NSCLC)",
author = "Eric Santoni-Rugiu and S{\o}rensen, \{Jens Benn\} and Urbanska, \{Edyta Maria\}",
year = "2025",
month = feb,
day = "28",
doi = "10.21037/tlcr-24-961",
language = "English",
volume = "14",
pages = "310--313",
journal = "Translational lung cancer research",
issn = "2218-6751",
publisher = "Pioneer Bioscience Publishing Company",
number = "2",
}